Dr. Rundén-Pran is senior scientist and section leader for Health Effects Laboratory and ERT registered toxicologist.
She has extensive experience in toxicology, nanotoxicology, nanosafety, cell cultures, 3D-cellular models, nanogenotoxicology, DNA damage, intracellular cell death signaling, microscopy (confocal, TEM), immunohistochemistry, tissue slice cultures and neurodegeneration.
She was part of the Centre for Excellence in Molecular Neurobiology and DNA repair (UiO) for several years (PhD and Postdoc). She is experienced with human risk assessment and regulatory toxicology, partner leader in EURONANOMED II projects GEMNS and INNOCENT, and NILU project leader for several projects funded by EU and NFR. She has extensive experience in GLP, and is appointed member of the national committee for approval of European registered toxicologists (ERT), The Norwegian Scientific Committee for Food and Environment, and member of the national expert group for toxicology.
The Health Effects Laboratory is certified for Good Laboratory Practice (GLP) for in vitro human toxicity studies. The laboratory is among the leading laboratories in Europe in nanotoxicology and nanosafety, and main areas of interest are genotoxicity, carcinogenicity in vitro, epigenetics, advanced in vitro models, regulatory aspects of nanosafety, high-throughput approach to toxicity testing, intelligent testing strategy and adverse outcome pathways.